Silexion Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery and development of treatments for KRAS-driven cancers. The company was founded on November 30, 2008 and is headquartered in in Modiin, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
14
Frequently Asked Questions
What is Market Cap of Silexion Therapeutics Corp?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Silexion Therapeutics Corp market cap is $3.11M.
What is the 52-week high for Silexion Therapeutics Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Silexion Therapeutics Corp 52 week high is $39.40 as of October 10, 2026.
What is the 52-week low for Silexion Therapeutics Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Silexion Therapeutics Corp 52 week low is $0.2079 as of October 10, 2026.
What is Silexion Therapeutics Corp stock price today?
Silexion Therapeutics Corp stock price today is $0.2146.
What was Silexion Therapeutics Corp stock price yesterday?
Silexion Therapeutics Corp stock price yesterday was $0.2349.
What is the Price-to-Book ratio of Silexion Therapeutics Corp?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Silexion Therapeutics Corp P/B ratio is 5.7549.
What is the 50-day moving average of Silexion Therapeutics Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Silexion Therapeutics Corp 50-day moving average is $0.569.
How many employees does Silexion Therapeutics Corp have?